Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PHVS compared with MNPR: revenue, margins and what each company keeps, and the suppliers and customers both name
PHVS
Pharvaris N.V.
Change
Mkt cap
Revenue
Revenue
MNPR
Monopar Therapeutics
Change
Mkt cap
Revenue
Revenue
vs
Compare
PHVS
Pharvaris N.V.
vs
MNPR
Monopar Therapeutics
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
PHVS
No earnings history for PHVS.
MNPR
Report
implied
realized
× implied
Q2 FY26
—
▲
+0.38%
—
May 14 '26
—
▼
−0.73%
—
Q1 FY26
—
▼
−0.84%
—
Q3 FY25
—
▲
+5.36%
—
= implied
PHVS realized, solid
MNPR realized, hatched
One scale, both sides: full bar = 6%
× = |realized| ÷ implied
Source: market data
PHVS
Pharvaris N.V.
Change
33.53
▼
−0.13%
· post 34.68
Mkt cap
$2.2B
MNPR
Monopar Therapeutics
Change
69.99
▼
−2.66%
· post 69.99
Closed
Oct 30 '26
Mkt cap
$472.0M
vs
Compare
Closed
Oct 30 '26
PHVS
Pharvaris N.V.
vs
MNPR
Monopar Therapeutics
33.53
▼
−0.13%
post 34.68
Price
69.99
▼
−2.66%
post 69.99
$2.2B
Mkt cap
$472.0M
Change
Change
PHVS
33.53
▼
−0.13%
vs
MNPR
69.99
▼
−2.66%
Closed
Oct 30 '26